International Conference on Neurogenetics and Molecular Neuroscience (ICNNMN - 26)

This track will explore the latest discoveries in neurogenetics, focusing on the genetic underpinnings of neurological disorders. Researchers will present novel findings that enhance our understanding of gene-environment interactions in brain function.

This session will delve into the molecular pathways involved in neurodegenerative diseases such as Alzheimer's and Parkinson's. Presentations will highlight recent research on cellular processes, protein misfolding, and neuroinflammation.

This track will discuss innovative gene therapy strategies aimed at treating genetic disorders affecting the nervous system. Experts will share insights on vector development, delivery methods, and clinical trial outcomes.

This session will focus on the identification and validation of genetic biomarkers for various neurological conditions. Researchers will present their findings on how these biomarkers can aid in diagnosis, prognosis, and treatment response.

This track will examine the genetic factors influencing neurodevelopmental disorders such as autism and ADHD. Presentations will address the interplay between genetic predispositions and environmental influences.

This session will explore the principles of personalized neuroscience, emphasizing the role of genetic information in developing tailored therapeutic strategies. Discussions will include case studies and the integration of genomic data into clinical practice.

This track will highlight cutting-edge molecular biology techniques and their applications in neuroscience research. Topics will include CRISPR technology, RNA sequencing, and proteomics in the study of brain function and disorders.

This session will focus on hereditary brain diseases, exploring the genetic mutations that contribute to their pathogenesis. Researchers will discuss the implications of these findings for diagnosis and potential therapies.

This track will cover the emerging field of neurogenomics, emphasizing the integration of genomic data with neuroscience. Presentations will showcase how large-scale genomic studies are reshaping our understanding of brain function and disease.

This session will investigate the molecular mechanisms underlying synaptic plasticity and their relevance to learning and memory. Researchers will present their findings on the role of specific genes and proteins in synaptic changes.

This track will address the ethical implications of neurogenetic research, including issues related to gene editing and genetic privacy. Discussions will focus on the responsibilities of researchers and the societal impact of their findings.